Roquefort Therapeutics plc Aktie - Unternehmensdaten & Kurse - GB00BMDQ2T15 | MoneyPeak

Roquefort Therapeutics plc

Share · GB00BMDQ2T15 (XLON)

No Price

Closing Price XLON 17.09.2025: 1,95 GBX

17.09.2025 09:19

Current Prices from Roquefort Therapeutics plc

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
London	ROQ.L	GBX	17.09.2025 09:19	1,95 GBX	0,08 GBX +4,28 %

Share Float & Liquidity

Free Float 54,69 %

Shares Float 86,11 M

Shares Outstanding 157,44 M

Company Profile for Roquefort Therapeutics plc Share

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Company Data

Name Roquefort Therapeutics plc

Company Roquefort Therapeutics plc

Website https://www.roquefortinvest.com

Primary Exchange

London

ISIN GB00BMDQ2T15

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Stephen Paul West CA

Country United Kingdom

Currency GBX

Employees 0,0 T

Address Eccleston Yards, SW1W 9NF London

IPO Date 2021-03-22

Ticker Symbols

Name	Symbol
London	ROQ.L

More Shares

Investors who hold Roquefort Therapeutics plc also have the following shares in their portfolio:

LIQUID TELE. 21/26 REGS Bond

SILVERSTONE MASTER ISSUER PLC 2019-1 CLS 1A RES M/BKD FRN 21/01/70 (A) Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025